Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion type Assertion NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_head.
- NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_provenance.
- NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion evidence source_evidence_literature NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_provenance.
- NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion SIO_000772 23585472 NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_provenance.
- NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion wasDerivedFrom befree-2016 NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_provenance.
- NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_assertion wasGeneratedBy ECO_0000203 NP1069209.RAazGDZ6O31lw0j1AlrINY1U36B_rdpgt_iZE5W1dqJuk130_provenance.